United Therapeutics | UTHR - Los Gastos De Explotación

Precio De Mercado
571.73
Cambio Diario
-3.04 -0.53%
Mensual
4.96%
Anual
103.35%
Q2 Expectativa
556.12




Los Gastos De Explotación Cambio Fecha
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Bayer EUR 10.33B 126M 2025-12
BioCryst Pharmaceuticals USD 146.17M 534.06M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
J&J USD 18.97B 2.38B 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Moderna USD 1.54B 259M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12